Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function

NCT05724693 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer
Hepatic Impairment

Interventions

DRUG: Bemnifosbuvir (BEM)

Sponsor

Atea Pharmaceuticals, Inc.